This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.20% per year. These returns cover a period from January 1, 1988 through April 1, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Zacks News
Charlotte, NC-based Albemarle Corporation is a premier specialty chemicals company with leading positions in attractive end markets globally. It is a leading producer of highly-engineered specialty chemicals geared to meet customer requirements across a bevy of end markets including petroleum refining, consumer electronics, energy storage, construction and automotive.
Olin (OLN) Surpasses Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Olin (OLN) delivered earnings and revenue surprises of 11.11% and 0.65%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Earnings Preview: Huntsman (HUN) Q1 Earnings Expected to Decline
by Zacks Equity Research
Huntsman (HUN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Analysts Estimate Albemarle (ALB) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Albemarle (ALB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Here's Why Albemarle (ALB) Gained But Lagged the Market Today
by Zacks Equity Research
The latest trading day saw Albemarle (ALB) settling at $112.29, representing a +0.12% change from its previous close.
Albemarle (ALB) Sees a More Significant Dip Than Broader Market: Some Facts to Know
by Zacks Equity Research
Albemarle (ALB) closed at $120.50 in the latest trading session, marking a -1.7% move from the prior day.
Here is What to Know Beyond Why Albemarle Corporation (ALB) is a Trending Stock
by Zacks Equity Research
Albemarle (ALB) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Albemarle (ALB) Stock Drops Despite Market Gains: Important Facts to Note
by Zacks Equity Research
In the closing of the recent trading day, Albemarle (ALB) stood at $129.16, denoting a -1.92% change from the preceding trading day.
Albemarle (ALB) Exceeds Market Returns: Some Facts to Consider
by Zacks Equity Research
In the closing of the recent trading day, Albemarle (ALB) stood at $128.87, denoting a +1.89% change from the preceding trading day.
Albemarle Corporation (ALB) Is a Trending Stock: Facts to Know Before Betting on It
by Zacks Equity Research
Zacks.com users have recently been watching Albemarle (ALB) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Why Is Huntsman (HUN) Down 2.3% Since Last Earnings Report?
by Zacks Equity Research
Huntsman (HUN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Albemarle (ALB) Surpasses Market Returns: Some Facts Worth Knowing
by Zacks Equity Research
Albemarle (ALB) closed the most recent trading day at $124.86, moving +0.33% from the previous trading session.
Investors Heavily Search Albemarle Corporation (ALB): Here is What You Need to Know
by Zacks Equity Research
Zacks.com users have recently been watching Albemarle (ALB) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Is Invesco S&P 500 Equal Weight Materials ETF (RSPM) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for RSPM
Why Is Albemarle (ALB) Up 2% Since Last Earnings Report?
by Zacks Equity Research
Albemarle (ALB) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Albemarle (ALB) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
Albemarle (ALB) closed the most recent trading day at $123.93, moving -0.66% from the previous trading session.
Should You Invest in the Invesco S&P 500 Equal Weight Materials ETF (RSPM)?
by Zacks Equity Research
Sector ETF report for RSPM
Albemarle Corporation (ALB) is Attracting Investor Attention: Here is What You Should Know
by Zacks Equity Research
Albemarle (ALB) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Albemarle (ALB) Accelerates Lithium Growth With $1.75B Offering
by Zacks Equity Research
Albemarle (ALB) is offering $1.75 billion in depositary shares to fund lithium operations growth and repay commercial paper.
Albemarle Corporation (ALB) Is a Trending Stock: Facts to Know Before Betting on It
by Zacks Equity Research
Albemarle (ALB) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Albemarle's (ALB) Earnings and Revenues Beat Estimates in Q4
by Zacks Equity Research
Albemarle's (ALB) fourth-quarter earnings and revenues surpass estimates on higher volumes in Energy Storage.
Albemarle (ALB) Reports Q4 Earnings: What Key Metrics Have to Say
by Zacks Equity Research
The headline numbers for Albemarle (ALB) give insight into how the company performed in the quarter ended December 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Markets Kiss & Make Up for Valentine's Day
by Mark Vickery
Investors were in a mood to kiss and make up from their stormy session yesterday.
Albemarle (ALB) Surpasses Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Albemarle (ALB) delivered earnings and revenue surprises of 86.87% and 2.90%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
This Week's 5 Must-See Earnings Charts
by Tracey Ryniec
What stocks will everyone be watching this week? Don't miss these five.
Albemarle (ALB) to Post Q4 Earnings: What's in the Cards?
by Zacks Equity Research
Albemarle (ALB) is likely to have benefited from higher lithium volumes and its cost-reduction actions in Q4 amid demand headwinds in specialties.